全球健康与长寿每日简报Global Health & Longevity Daily Briefing

中UCLA团队10月4日发表研究，将特定肠道细菌及其代谢副产物与大脑生物性衰老速度挂钩：肠道显得更老者伴随更差记忆、专注力与情绪。代谢物可经血脑屏障影响脑内炎症与神经递质环境，提示脑衰老迹象或可比临床症状早数十年出现，菌群构成可通过膳食纤维与发酵食品干预，为痴呆预防提供可调节靶点。

ENA UCLA team reported on October 4 that specific gut bacteria and their metabolic byproducts track the biological aging speed of the brain: people with older-looking brains also reported poorer memory, focus and mood. Microbial metabolites crossing the blood-brain barrier shape inflammation and neurotransmitter signaling, suggesting brain-aging signs may appear decades before symptoms - and because the microbiome is diet-responsive, it offers modifiable prevention targets.

中科学家鉴定出UBE2N酶可能是对抗脂肪肝恶化的天然防线：该酶帮助肝细胞清除受损线粒体并分解脂肪，从而减轻炎症、纤维化与细胞损伤，延缓其向更危险的MASH（代谢功能障碍相关脂肪性肝炎）进展。该研究影响约1亿美国人的疾病领域，为线粒体质量控制在代谢性肝病中的作用再添证据。

ENScientists identified the enzyme UBE2N as a potential natural defense against worsening fatty liver disease, which affects an estimated 100 million Americans: UBE2N helps liver cells clear damaged mitochondria and break down fat, limiting the inflammation, scarring and cell injury that drive progression to the more dangerous condition MASH, adding fresh evidence for mitochondrial quality control in metabolic liver disease.

中浙江某三甲医院公布国产Akkermansia菌株AKK001落地产品的随机双盲对照人体临床：60名BMI≥28受试者每日补充1.5×10¹⁰ TFU连续12周，平均体重下降7.2公斤、甘油三酯下降21%，第4周即见基础代谢率升5.17%、皮下脂肪面积减7.8%。业内认为这标志益生菌产业从菌株科研叙事走向人体证据，呼应新国标征求意见稿对菌株鉴定与人体试食试验的要求。

ENA tertiary hospital in Zhejiang released randomized double-blind human trial data for the domestic Akkermansia muciniphila product AKK001: 60 adults with BMI≥28 took 1.5×10¹⁰ TFU daily for 12 weeks, losing an average 7.2 kg with triglycerides down 21%; by week 4 resting metabolic rate rose 5.17% and subcutaneous fat area fell 7.8%. Observers call it a shift from strain-level science toward human evidence, aligned with draft Chinese probiotic standards requiring strain ID and human feeding trials.

中东英吉利大学与Oxford BioDynamics发表于Journal of Translational Medicine的研究，用3D基因组平台分析长新冠、ME/CFS、PTSD、类风湿关节炎与多发性硬化五种疾病：单基因层面几乎不重叠，但基因网络共同指向免疫炎症信号、线粒体能量生产、代谢调控与神经内分泌应激通路，或解释截然不同的病因为何导致相似的致衰性疲劳，并为血液生物标志物与新疗法铺路。

ENA University of East Anglia and Oxford BioDynamics study in the Journal of Translational Medicine analyzed long Covid, ME/CFS, PTSD, rheumatoid arthritis and multiple sclerosis with 3D-genomic profiling: individual genes barely overlap, yet their networks converge on immune-inflammatory signaling, mitochondrial energy production, metabolic regulation and neuroendocrine stress pathways - explaining why different triggers yield similarly devastating fatigue and opening routes to blood biomarkers and therapies.

中第13届衰老研究与药物发现会议（ARDD）10月1日在哈佛开幕，规模创历届之最。哈佛医学院院长Daley以医疗事故警示长寿干预必须建立在科学与监管严谨之上；FDA高层首次明确将在监管科学重点文件中纳入衰老与长寿，并提出两类审批路径——逐病累积证据或直接以死亡/衰弱等硬终点开展老年人群试验，标志该领域获监管层制度性认可。

ENThe 13th Aging Research and Drug Discovery meeting opened at Harvard on October 1 as its largest ever. Dean George Daley warned that longevity interventions must earn trust through evidence after a wellness-center death, and senior FDA officials said for the first time that aging and longevity will be explicitly included in the agency's regulatory-science focus document, outlining two approval routes - disease-by-disease evidence or hard endpoints such as mortality and frailty in aging populations.

中诺和诺德与礼来首次在ARDD 2026主舞台展示GLP-1药物衰老终点数据：诺和诺德基于SELECT试验效应的英国真实世界队列（1.9万人）模型预测司美格鲁肽带来平均1.9个生命年增益，蛋白组学生物年龄在13-20周内下降；礼来SURMOUNT-5表观遗传子研究显示替尔泊肽72周后15个时钟全部显示衰老慢于时间流逝，DunedinPACE中位数由1.13降至1.08。两家均强调数据仍属早期探索。

ENNovo Nordisk and Eli Lilly presented aging-endpoint data for GLP-1 drugs on the ARDD 2026 main stage for the first time: Novo modeled a mean 1.9 life-year gain for semaglutide from SELECT effect estimates in a 19,117-person UK cohort, with proteomic biological age falling within 13-20 weeks; Lilly's SURMOUNT-5 epigenetic sub-study found all 15 clocks showed less aging than elapsed time on tirzepatide, with median DunedinPACE dropping from 1.13 to 1.08. Both stressed the signals remain early.

中Live Forever Club报道10月2日DoNotAge科学大会要点：罗切斯特大学Gorbunova指出长寿动物SIRT6活性更高、百岁老人携带更高频SIRT6等位基因、褐藻来源岩藻多糖为其激活剂；奥胡斯团队发现亚精胺水平随龄下降且可促肌肉干细胞增殖；兰卡斯特20天槲皮素试验使健康人收缩压降约7 mmHg并将扩展至高血压前期人群，为长寿补剂管线提供临床线索。

ENCovering DoNotAge's October 2 science conference, Live Forever Club highlights: Rochester's Vera Gorbunova on SIRT6 being more active in long-lived animals and more common SIRT6 alleles in centenarians, with fucoidan from brown seaweed as an activator; Aarhus data that spermidine declines with age and boosts muscle stem cell proliferation; and a 20-day quercetin trial cutting systolic blood pressure about 7 mmHg in healthy adults, now extending to prehypertension.

中10月2-3日第四届Healthspan Summit在洛杉矶举行，逾千名临床医生与创业者参会。长寿医学临床轨道的主线是客观测量优先：Vexon Med等以综合生理测试提炼单一基线评分，再叠加运动处方、营养咨询、循证补剂与激素优化进行纵向管理；医用级光生物调节、声振疗法等康复手段加速进入临床场景，SNiP营养基因组学则推动DNA导向个性化营养，勾勒长寿医学的标准化诊疗雏形。

ENThe 4th Healthspan Summit drew 1,000-plus clinicians and founders to Los Angeles on October 2-3. The clinical track's throughline was objective measurement first: practices like Vexon Med distill comprehensive physiologic testing into a single baseline score before layering exercise prescription, nutrition counseling, evidence-based supplementation and hormone optimization for longitudinal care, while medical-grade photobiomodulation, vibroacoustic therapy and DNA-guided nutrigenomics push longevity medicine toward a structured standard of care.

中热心肠日报10月5日导读Nature子刊研究：在21种人肠菌合成群落中投放94种膳食成分，过半多糖显著推高普雷沃氏菌Segatella copri丰度并压缩拟杆菌；关键在于大肠杆菌这一“外援”——即便敲除其利用阿拉伯聚糖单糖的基因仍能恢复S. copri竞争优势，提示游离单糖充当信号分子触发与营养无关的级联反应，为膳食纤维精准搭配重塑菌群提供机制依据。

ENA Nature-family journal study featured by ChinaGut Daily on October 5 screened 94 dietary components in a 21-species synthetic human gut community: over half the polysaccharides boosted Segatella copri at the expense of Bacteroidaceae. Crucially, commensal E. coli restored S. copri's competitive edge even when its arabinan-sugar utilization genes were knocked out, implying free sugars act as signal molecules triggering nutrition-independent cascades - mechanistic grounding for precision fiber pairing to reshape the microbiome.

中热心肠日报10月5日第3745期头条：温州医科大学郑宏团队发现糖尿病认知衰退患者与小鼠模型中Akkermansia（阿克曼氏菌）持续偏低而血亮氨酸升高——Akk菌具备降解亮氨酸的酶系，其耗竭致亮氨酸蓄积，过量亮氨酸经TBK1-OPTN磷酸化级联引发神经元过度线粒体自噬；补亮氨酸加重而限亮氨酸改善小鼠认知，为肠-脑代谢轴干预糖尿病脑病提供新靶点。

ENLeading ChinaGut Daily's October 5 issue: Zheng Hong's team at Wenzhou Medical University found low Akkermansia and high circulating leucine in diabetic patients and mice with cognitive decline. Akkermansia carries the enzymatic machinery to catabolize leucine, so its depletion lets leucine accumulate and, via TBK1-OPTN phosphorylation, drives excessive neuronal mitophagy; leucine supplementation worsened while deprivation protected cognition in mice, framing a gut-brain metabolic axis against diabetic encephalopathy.

中EASD 2026年会多项研究描绘饮食干预糖尿病新图景：餐盒配送的低碳水高蛋白饮食12个月改善2型糖尿病异位脂肪；DANCE试验显示低碳水饮食对1型糖尿病同样有益；荷兰抗生素干预试验证实肠菌色氨酸代谢物IPA为菌源、与血糖变异性负相关；蔗糖酶-异麦芽糖酶缺乏的格陵兰人群食物偏好不同、中链脂肪酸可诱导促红细胞生成，凸显个体化营养的生物学基础。

ENEASD 2026 studies sketch a multidimensional picture of dietary intervention in diabetes: meal-kit-delivered carbohydrate-reduced high-protein diets improved ectopic fat over 12 months; the DANCE trial showed low-carb diets benefit type 1 diabetes; a Dutch antibiotic intervention confirmed the tryptophan metabolite IPA is gut-derived and inversely tied to glycemic variability; and sucrase-isomaltase deficiency plus MCT-induced erythropoietin responses underscore the biology behind personalized nutrition.

中生物通10月4日推介The Journal of Nutrition综述：系统梳理面向老年人的功能性食品四大活性成分——多酚、生物活性肽、益生菌与维生素，及乳液、微胶囊、水凝胶、脂质体等递送系统在稳定性、生物利用度与靶向释放上的进展；同时指出载体长期安全性、感官接受性、工业化与法规标准仍是瓶颈，呼吁以多组学驱动个性化配方并加强多病共存老年人群临床验证。

ENA Journal of Nutrition review highlighted by BioTrade on October 4 maps the four key bioactives in functional foods for older adults - polyphenols, bioactive peptides, probiotics and vitamins - and how emulsion, microcapsule, hydrogel and liposome delivery systems improve stability, bioavailability and targeted release. Long-term carrier safety, sensory acceptance, industrial scale-up and regulatory standards remain bottlenecks; the authors call for multi-omics-driven personalized formulations and trials in older adults with multimorbidity.

中生物通10月2日报道：三种含co-biotic（共益体）化合物的新配方——复合维生素DM-02、能量专注型AM-02与助眠型PM-02，在6名健康成人粪便接种的离体SIFR结肠发酵模型中，均显著降低pH并提升总短链脂肪酸9-11%，AM-02与PM-02还使丁酸增20%、丙酸增7-8%，且富集产SCFA与B族维生素菌群、不增加产气，为共益体配方的临床评价奠定机制基础。

ENCovered by BioTrade on October 2: three novel co-biotic supplement formulas - multivitamin DM-02, energy/focus AM-02 and sleep PM-02 - tested in a validated ex vivo SIFR colonic fermentation model (n=6 healthy adults) all lowered pH and raised total short-chain fatty acids 9-11%; AM-02 and PM-02 lifted butyrate 20% and propionate 7-8%, enriched SCFA- and B-vitamin-producing taxa, and produced no extra gas, laying mechanistic ground for clinical evaluation of co-biotics.

中NutraIngredients 10月2日科研合辑：发表于Complementary Therapies in Clinical Practice的研究显示，健康人短期补充生姜可提升胆固醇外流能力（CEC）并改善抗氧化应答——CEC是冠脉事件的反向预测指标；另有Asahi研究称单剂热灭活加氏乳杆菌CP2305后生元可提升放松相关脑α波与副交感活性，为心血管与情绪类补剂提供新证据。

ENNutraIngredients' October 2 round-up: research in Complementary Therapies in Clinical Practice shows short-term ginger supplementation enhances cholesterol efflux capacity (CEC) - an inverse predictor of coronary events - and improves antioxidant response in healthy adults; separately, Asahi reports that a single dose of heat-treated Lactobacillus gasseri CP2305 postbiotic raised relaxation-linked alpha brain activity and parasympathetic tone and boosted serotonin secretion in intestinal cell models.

中ScienceDaily 10月4日报道：高剂量维生素B3（烟酸）作为标准治疗补充展现早期潜力——小型试验中82%的胶质母细胞瘤患者六个月保持无进展生存。研究者认为烟酸或可唤醒被肿瘤压制的免疫细胞，但样本量小，获益与安全性仍需更大规模研究确认，此为常见维生素转攻最凶险脑癌的探索性一步。

ENScienceDaily reported on October 4 that high-dose vitamin B3 (niacin) is showing intriguing early promise as an addition to standard glioblastoma treatment: 82% of patients in a small trial remained progression-free after six months. Researchers believe niacin may help revive immune cells suppressed by the cancer, but the sample is small and larger studies are still needed to confirm benefit and safety for one of the deadliest brain cancers.

中ScienceDaily报道：维生素D类似物或有助于瓦解胰腺癌的致密保护性防御，使肿瘤更易受化疗与免疫攻击；小型临床试验显示鼓舞人心的应答，尤其是维生素D受体水平较高的肿瘤患者。胰腺癌被称为“癌王”，基质屏障是其治疗 resistance 的关键，该策略若经更大规模验证，或为改善预后提供新路径。

ENScienceDaily reports that a vitamin D analog may help break down pancreatic cancer's dense protective defenses, making tumors more vulnerable to chemotherapy and immune attack; a small clinical trial found encouraging responses, especially in patients whose tumors had high levels of the vitamin D receptor. With the stromal barrier central to pancreatic cancer's notorious drug resistance, the strategy could open a new route to better outcomes if validated at scale.

中美国糖尿病学会与欧洲糖尿病研究协会10月2日发布2026版共识报告，接替2022版：倡导确诊早期即考虑具心肾获益的SGLT2抑制剂与GLP-1类药物，以“站立、步走、出汗、力量与睡眠”五主题整合全天健康行为，强调治疗方案须与个体病情、偏好与可负担性匹配；HbA1c仍是基石，但心、肾、体重与情绪健康共同构成管理目标。

ENThe ADA and EASD published their 2026 consensus report on October 2, updating 2022: earlier consideration of SGLT2 inhibitors and GLP-1 therapies with proven heart and kidney benefits, a whole-day behavior framework of standing, stepping, sweating, strengthening and sleep, and explicit matching to individual conditions, preferences and affordability. HbA1c remains foundational, but heart, kidney, weight and emotional wellbeing now share the management stage.

中发表于Lancet Regional Health Americas并在EASD 2026报告的RESET for Remission试验：96名45岁前确诊的早发2型糖尿病肥胖成人随机接受24周800-900千卡/日低能量饮食加监督下有氧与抗阻运动，54%达到缓解（HbA1c<6.5%且停药12周以上），对照组仅4%；干预组平均减重8.4公斤且保留肌肉量、改善体能与心血管指标，无严重不良事件。

ENThe RESET for Remission trial, published in the Lancet Regional Health Americas and presented at EASD 2026: 96 adults with early-onset type 2 diabetes and obesity were randomized to 24 weeks of an 800-900 kcal/day low-energy diet plus supervised aerobic and resistance exercise. Remission (HbA1c below 6.5% off glucose-lowering drugs for 12 weeks) was achieved by 54% versus 4% on usual care, with 8.4 kg mean weight loss, preserved muscle mass, better fitness and cardiovascular measures, and no serious adverse events.

中一项纳入493名超重或肥胖成人的两年随机对照试验显示：以阿斯巴甜、安赛蜜或三氯蔗糖甜化的无糖软饮料在长期减重与维持上与水效果基本相当，两组体重、腰围、体成分及多项代谢指标改善幅度接近。结果挑战“代糖干扰代谢”的部分担忧，但研究者提示仍需结合个体反应与整体膳食质量解读，不宜简单化推广。

ENA two-year randomized trial in 493 adults with overweight or obesity found that diet soft drinks sweetened with aspartame, acesulfame-K or sucralose were essentially as effective as water for long-term weight loss and maintenance, with similar improvements in weight, waist size, body composition and several metabolic measures in both groups. The results temper some concerns that non-nutritive sweeteners derail metabolism, though researchers caution that individual responses and overall diet quality still matter.

中人民网四川频道10月4日报道，四川省疾控中心发布10月健康提示：秋冬交替叠加国庆假期人员流动，重点防范蚊媒传染病、流感、新冠、感染性腹泻与手足口病五类风险；儿童、老年人、学生与慢性病患者等重点人群及时接种流感疫苗，出现高热肌肉酸痛不带病上班上学；居家每日开窗通风2-3次、每次不少于30分钟。

ENPeople's Daily Online Sichuan reported on October 4 that the Sichuan Provincial CDC issued its October advisory: with the autumn-winter transition and heavy National Day travel, five risks take priority - mosquito-borne disease, influenza, Covid-19, infectious diarrhea and hand-foot-mouth disease. Priority groups including children, seniors, students and chronically ill residents should get flu shots promptly, stay home when febrile, and ventilate rooms two to three times daily for at least 30 minutes.